Find clinical trials for Pancreatic Cancer in San Antonio, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near San Antonio, TX, USA:
and clinical activity of AB680 in combination with Zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...
Phase 1
San Antonio, Texas, United States of America and 17 other locations
This study will test the effectiveness (anti-tumor activity), safety, and ability to increase the body's immune system to fight pancreatic...
Phase 2
San Antonio, Texas, United States and 2 other locations
The purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumors with KRAS mutation...
Phase 1
San Antonio, Texas, United States and 3 other locations
is to evaluate the safety and tolerability of RMC-9805 as monotherapy and in combination with RMC-6236 in adults with KRAS G12D-mutant solid tumors...
Phase 1
San Antonio, Texas, United States and 16 other locations
Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors....
Phase 1
San Antonio, Texas, United States and 15 other locations
The study is a first-in-human (FIH), open-label, multi-center phase 1/2 study of TSN1611 in subjects with KRAS G12D mutant advanced solid tumors...
Phase 1, Phase 2
San Antonio, Texas, United States and 5 other locations
dose-escalation, safety, pharmacokinetics (PK), and biomarker study of CBX-12 in subjects with advanced or metastatic refractory solid tumors...
Phase 1, Phase 2
San Antonio, Texas, United States and 3 other locations
administered orally as monotherapy in patients with advanced solid tumors with gene alterations in the RAS- MAPK pathway for whom there are ...
Phase 1
San Antonio, Texas, United States and 7 other locations
study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-2-307-ADC in patients with advanced cancer...
Phase 1
San Antonio, Texas, United States of America and 11 other locations
activity of MOMA-313 administered orally as a single agent or combination therapy in patients with homologous recombinant deficient solid tumors...
Phase 1
San Antonio, Texas, United States and 10 other locations
Clinical trials
Research sites
Resources
Legal